… medical benefits, however, when profit becomes the driving force, priorities shift. Pharmaceutical … , non-patentable treatments or preventive care … drug.  Some well-known examples are Merck’s Vioxx, … of antidepressant trials, “the 21 positive trials produced …

… profitable-cancer-vax-1121514417.html Merck Charged With Hiding Crippling … s number 2 drugmaker is facing a jury trial after being … settlement to victims of Vioxx, an inflammatory drug found to cause … -rein-in-drug-makers-big-food-and-the-fda-1120899370.html …

Merck & Co. is facing its first jury trial over … stakes litigation for the pharmaceutical giant. Lawyers for a … Merck’s Gardasil marketing campaign failed to warn consumers and their doctors … drug Vioxx caused heart attacks and strokes. Last year, Merck …

… as he explores the medical history behind rheumatic diseases … of non-steroidal anti-inflammatory drugs (NSAIDs). And in a … DO, Healio Rheumatology’s chief medical editor, Calabrese provided a debrief … the rise and fall of VIOXX teach us about physiology? …

… Amendment, the FDA relaxed its rules, allowing drug advertisers to … Merck’s TV ads helped make the painkiller Vioxx a … drugs that have transformed the treatment of obesity. The pharmaceutical … drug ads, he could find allies among doctors. The American Medical …

… has been developed as a treatment for opioid addiction, the … This was after the FDA had published information on the … For instance, Merck’s legal battle over their drug Vioxx cost the … of the ripple effects of pharmaceutical lawsuits, balancing risks with …

… of medical mistakes: the pharmaceutical and medical device industries … better-known Vioxx case, where Merck heavily … trial. The FDA warning states women taking an estrogen/progestin combination drug … reported health habits, treatments, and outcomes …

… rollout of Merck’s pain reliever Vioxx in 1999. … doctors by chance stumbled upon drugs that evolved into treatments for mental illness. Medicines … and learned that Takeda Pharmaceutical had developed and … economics department of a biotech firm. Before taking …

… be you. While most doctors and government officials at … the pharmaceutical industry," you told PBS after the Vioxx … Journal of the American Medical Association (JAMA). "Dr … Johnson & Johnson, Scios, Merck/Schering-Plough, Schering-Plough …

… phase 3 trials, achieved by examining medication use … , such as price, pharmaceutical form, strength, and … medication history being left truncated for selected treatments … Drug withdrawals and the utilization of therapeutic substitutes: the case of Vioxx …